When we designed a series of high-affinity compounds for CA IX as potential anticancer agents, it was necessary to demonstrate that these compounds recognize and bind exclusively to CA IX, whose expression increases upon growing cancer-cell cultures under hypoxia. Here, CA9 is linked to cancer.